EMERITI PHARMA AB
Emeriti Pharma AB develops a whole new treatment against skin disease rosacea. Today, rosacea is treated for a long time with different creams or antibiotic tablets. However, treatment is not so effective, it takes a long time to see results and the disease often returns after completion of treatment. Emeriti Pharma, a privately owned Swedish company, was founded in 2014 by former AstraZeneca scientists representing a wide knowledge of pharmaceutical research and development, often with many years in leading positions, and with experience of taking innovative drugs to the market.
EMERITI PHARMA AB
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2014-01-01
Address:
Mölndal, Vastra Gotaland, Sweden
Country:
Sweden
Website Url:
http://www.emeritipharma.se
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
2 M SEK
Technology used in webpage:
Domain Not Resolving
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
Investors List
Almi Invest
Almi Invest investment in Seed Round - Emeriti Pharma AB
